Pharmacological treatment for attention deficit hyperactivity disorder in children with co-morbid tic disorders

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2009, Pages

  Pringsheim, Tamara ^a   Steeves, Thomas ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b Movement Disorders Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMPHETAMINE; ATOMOXETINE; METHYLPHENIDATE; PLACEBO; TRICYCLIC ANTIDEPRESSANT AGENT;

ATTENTION DEFICIT DISORDER; CELL HETEROGENEITY; CLINICAL TRIAL; COMORBIDITY; DATA ANALYSIS; DISEASE SEVERITY; DRUG EFFECT; FOLLOW UP; HUMAN; INFORMATION PROCESSING; QUESTIONNAIRE; RATING SCALE; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS; TIC; TREATMENT OUTCOME;

EID: 70049088845     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007990     Document Type: Review

References (22)

1. th edition, Text Revision.. Diagnostic and Statistical Manual of Mental Disorders, 4th edition, Text Revision. Washington DC: American Psychiatric Association, 2000.
2. Buccafusco JJ. Neuropharmacologic and behavioural actions of clonidine: interactions with central neurotransmitters. Int Rev Neurobiol 1992;33:55-107.
3. Bymaster FP, Katner JS, Nelso DL. Atomoxetine increases extracellular levels of norephinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in ADHD. Neuropsychopharmacology 2002;27:699-711.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders III. Washington DC: American Psychiatric Association, 1980.
5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd edition, revised.. Washington DC: American Psychiatric Association, 1987.
6. American Psychiatric Association. Diagnostic and Statistical Manual for Psychiatry. Edition 4.. Washington D.C.: American Psychiatric Association, 1994.
7. Egger M, Davey-Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphic test. British Medical Journal 1997;315(7):629-634. (Pubitemid 27387172)
8. Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology 2002;31(1):140-149 (Pubitemid 34284916)
9. Freeman RD, Fast DK, Burd L, Kerbeshian J, Robertson MM, Sandor P. An international perspective on Tourette syndrome: selected finding from 3500 individuals in 22 countries. Developmental Medicine and Child Neurology 2000;42:436-447. (Pubitemid 30427051)
10. Golden GS. Gilles de la Tourettes syndrome following methylphenidate administration. Developmental Medicine and Child Neurology 1974;16:76-78.
11. Harris RD, Helfand M, Woolf SH, Lohr KN, Mulrow CD. Current methods of the US Preventive services task force. A review of the process. American Journal of Preventive Medicine 2001;20:21-35. (Pubitemid 33732964)
12. Higgins J, Altman D. Assessing risk of bias in included studies. In: Higgins J, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Chichester: Wiley Blackwell, 2008:187-241.
13. World Health Organization. ICD-10: international statistical classification of diseases and related health problems: tenth revision.. Geneva: World Health Organization, 2004.
14. Kurlan R, Como PG, Miller B, Palumbo D, Deeley C. The behavioural spectrum of tic disorders. A community based study. Neurology 2002;59:414-420. (Pubitemid 34857935)
15. Lowe TL, Cohen DJ, Detlor M, Kremenitzer MW, Shaywitz BA. Stimulant medications precipitate Tourettes syndrome. JAMA 1982;247:1729-1731 (Pubitemid 12192968)
16. Pringsheim T, Lang A, Kurlan R, Pearce M, Sandor P. Health related quality of life in children with TS. Neurology 2007;68:A294.
17. Seiden LS, Sabol KE, Ricaurte GA. Amphetamine: effects on catecholamine systems and behaviour. Annual Review of Pharmacology and Toxicology 1993;33:639-677. (Pubitemid 23116021)
18. Spencer T, Biederman J, Faraone S, Mick E, Coffey B, Geller D, Kagan J, Bearman S, Wilens T. Impact of tic disorders on ADHD outcome across the life cycle: findings from a large group of adults with and without ADHD. American Journal of Psychiatry 2001;158:611-617. (Pubitemid 32289825)
19. Sukhodolsky DG, Scahill L, Zhang H, Peterson BS, King RA. Disruptive Behaviour in Children with Tourettes Syndrome: Association with ADHD Comorbidity, Tic Severity, and Functional Impairment.. Journal of the American Academyof Child and Adolescent Psychiatry 2003;42:98-105. (Pubitemid 39610619)
20. The Tourette's Syndrome Study Group. Treatment of ADHD in children with tics. Neurology 2002;58:527-536
21. World Health Organisation. International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10). Geneva: World Health Organisation, 1992.
22. Wilens TE. Mechanism of action of agents used in attention deficit/hyperactivity disorder. Journal of Clinical Psychiatry 2006;67 (supplement 8):32-37.